LDRT
Clinical trials for LDRT explained in plain language.
Never miss a new study
Get alerted when new LDRT trials appear
Sign up with your email to follow new studies for LDRT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy hopes to boost immune attack on tough pancreatic cancer
Disease control Recruiting nowThis study tests whether adding low-dose radiation and an immunotherapy drug (pultelimab) to standard treatment can help shrink tumors in people with advanced pancreatic cancer. About 10 adults who have not had immunotherapy before will take part. The goal is to see if the combin…
Matched conditions: LDRT
Phase: PHASE1, PHASE2 • Sponsor: Zhejiang Provincial People's Hospital • Aim: Disease control
Last updated May 26, 2026 05:04 UTC
-
Low-dose radiation plus immunotherapy shows promise for liver-limited colorectal cancer
Disease control Recruiting nowThis early-phase trial tests whether adding low-dose radiotherapy to standard immunotherapy and chemotherapy is safe for people with colorectal cancer that has spread only to the liver. About 9 to 18 adults who have not had prior treatment will receive the combination. The main g…
Matched conditions: LDRT
Phase: PHASE1 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated May 22, 2026 14:04 UTC